In the USA the license for a new medicine from AIDS is given out

Management under the control over products and medicines of the USA has licensed for manufacture and sale of a new medicine for a HIV.

It represents a pill containing three medicinal preparations; to accept it it is necessary once a day.

The medicine has been created in common by companies Bristol-Myers-Squibb and Gilead Sciences and refers to Atripla.

It is calculated on those patients it is necessary for them to accept some preparations simultaneously.

It is expected, that the license for distribution Atripla in the Europe will be given out in following to year.

The pill includes a combination of the most widespread preparations which use a AIDS -infected. It became possible owing to cooperation between two companies which make them.

Now patients should accept every day less pills, than several years ago. For them it is very important to adhere to a precise mode of acceptance of medicines, and the new pill just and facilitates this problem.

However, Atripla - a medicine not for all: it will be manages to one person more than in 1000 dollars a month.